RE: Recent Analyst Comments23 Jan 2021 13:14
Banking is very different, they have to hold capital to absorb shocks in the financial systems also with retail banks, low interest environment is impacting them. If interest rates rise so do banks profitability, but with so much debt and one crisis to another rates have been artificially low for a long time, we should have seen rates get back to a higher level and they havent and with recent cuts it is impacting them. Investment banks are different animals and make there money from trading and serving big businesses, why you see someone like Goldman make money during this pandemic.
The separation of the business is good as they believe it will create more value for shareholders spinning off, also the cost synergies will help with reinvesting and partnering with Pfizer to spin out is a smart move, Pharmas will always be around hence a defensive stock, GSK pipeline and R&D hasnt been great but the new Board have noticed this and are starting to invest. If the dividend is cut its not a bad thing as the current yield is c6% most organisations have cut or stopped dividends, dont think GSK need to but if they do to reinvest it wont be a bad idea, but they are still highly profitable and the dividend cover has been of the range of 1 to 2. Compare this to Astra who do not have enough coverage yet they are still paying highly.